Evidence map›Paper›PMID 35578218›Full record

ArticleBMC pulmonary medicine2022

Unusual presentation of lepidic adenocarcinoma in a healthy female.

Zaheer Akhtar, Leah Laageide, Julian Robles, Christopher Winters, Geoffrey C Wall, James Mallen, Zeeshan Jawa

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC pulmonary medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Zaheer AkhtarPGY3 Internal Medicine Resident, Department of Medical Education, UnityPoint Health, Des Moines, IA, USA. zaheerakhtarmed@gmail.com.ORCID http://orcid.org/0000-0001-9782-9824
Leah LaageideDepartment of Medicine, UnityPoint Health, Des Moines, IA, USA.
Julian RoblesDepartment of Medicine, UnityPoint Health, Des Moines, IA, USA.
Christopher WintersDepartment of Surgery, UnityPoint Health, Des Moines, IA, USA.
Geoffrey C WallDrake College of Pharmacy and Health Sciences, Des Moines, IA, USA.
James MallenDepartment of Pulmonology, The Iowa Clinic and UnityPoint Health, Des Moines, IA, USA.
Zeeshan JawaJohn Stoddard and Mission Cancer Center, Des Moines, IA, USA.
UnityPoint Health · USDrake University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLepidic adenocarcinoma represents a histologic pattern of non-small cell lung cancer that characteristically arises in the lung periphery with tracking alongside pre-existing alveolar walls. Noninvasive and invasive variants of lepidic adenocarcinoma are dependent on parenchymal destruction, vascular, or pleural invasion. The lepidic-predominant lung malignancies are collectively recognized as slow growing with rare metastasis and excellent prognosis. The World Health Organization classification of lung malignancies depends on molecular and histopathological findings. CT findings most commonly include ground-glass characteristics, commonly mistaken for inflammatory or infectious etiology. These tumors are generally surgically resectable and associated with better survival given infrequent nodal and extrathoracic involvement. Rarely these tumors present with diffuse pneumonic-type involvement associated with worse outcomes despite lack of nodal and distant metastases. CASE PRESENTATION: A 63-year-old Caucasian athletic immunocompetent female presented with 2 months of progressive shortness of breath, fatigue, loss of appetite and 15 pound weight loss. History was only notable for well controlled essential hypertension and hypothyroidism. Contrast computed tomography angiogram and positron emission tomography revealed diffuse hypermetabolic interstitial and airspace abnormalities of the lungs without lymphadenopathy (or distant involvement) in addition to right hydropneumothorax and left pleural effusion. Baseline laboratory testing was unremarkable, and extensive bacterial and fungal testing returned negative. Bronchoscopy and video-assisted thoracoscopic surgery was subsequently performed with pleural fluid cytology, lung and pleural biopsies returning positive for lepidic adenocarcinoma with 2% programmed death ligand 1 expression and genomic testing positive for PTEN gene deletion. Prior to treatment, the patient perished on day 15 of admission.

conclusionWe present a rare case of lepidic predominant adenocarcinoma with extensive bilateral aerogenous spread in the context of no lymphovascular invasion in a healthy, low risk patient. This case presentation may add to the body of knowledge regarding the different behavior patterns of lepidic predominant adenocarcinomas.

Indexed as

AdenocarcinomaAdenocarcinoma of LungCarcinoma, Non-Small-Cell LungLung NeoplasmsFemaleHumansMiddle AgedPrognosisAdenocarcinomaBronchioloalveolar carcinomaCase reportLepidic patternMicronodular infiltratesNon small cell lung cancer

Identifiers

PMID35578218
PMCPMC9109452
OpenAlexW4280570307

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.